Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 12, 2002
Toys are a potential source of cross-infection in general practitioners' waiting roomsEileen Merriman, Paul Corwin, Rosemary Ikram
European Heart Journal. Case Reports|April 26, 2019
Extensive intracardiac thrombi in a patient with heart failure and hepatic congestion: a case reportBernard Wong, Timothy Glenie, Eileen Merriman, et al.
Internal Medicine Journal|July 21, 2020
Fixed-dose three-factor prothrombin complex concentrates is safe and effective in warfarin reversalKirsty Marshall, Eileen Merriman, Merit Hanna, et al.
Thrombosis and Haemostasis|November 23, 2021
Retrospective Analysis of the Effectiveness of a Reduced Dose of Idarucizumab in Dabigatran ReversalLouisa Stone, Eileen Merriman, Merit Hanna, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 1, 2022
Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell TransplantMay Chiu, Samuel Hague, Anna Elinder-Camburn, et al.
Internal Medicine Journal|September 15, 2021
Management of single subsegmental pulmonary embolism: a prospective observational study at North Shore and Waitakere Hospitals, AucklandJian Li, Vicki Rolfe-Vyson, Valerie Rowland, et al.
Thrombosis Research|May 31, 2011
PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic riskLouise Bobbitt, Eileen Merriman, Jacqueline Raynes, et al.
The Medical Journal of Australia|November 25, 2024
Updated recommendations for warfarin reversal in the setting of four-factor prothrombin complex concentrateDanielle Robinson, James McFadyen, Eileen Merriman, et al.
Journal of Geriatric Oncology|December 15, 2021
Electronic FRAIL score as a predictor of treatment outcomes in older patients with diffuse large B-cell lymphomaJesse Zhang, Patricia Disperati, Anna Elinder-Camburn, et al.
Internal Medicine Journal|April 25, 2022
Real-world decision-making in the management of patients presenting with major bleeding on rivaroxaban: the Auckland regional experienceBrian T Grainger, Eileen Merriman, Gordon Royle, et al.
Pageof 3